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The male specific antigen (H-Y) has been implicated in the rejection of male 
skin grafts  by  syngeneic female  mice  and with the  production of anti-H-Y 
antibodies (1-4). 
Antisera against the mouse H-Y antigen react with heterogametic cells in 
mammals (including man), birds, and amphibians (5-8). Thus, the H-Y antigen 
seems  to  be  phylogenetically conserved,  and  it  has  been  argued  that  the 
serologically detectable H-Y antigen has an invariant function in testis induc- 
tion during embryonic development (9). 
It  has  also  been  suggested  (10) that  the  H-Y  antigen  is  associated  with 
antigens  of  the  major  histocompatibility  complex  (MHC) 1  on  the  plasma 
membrane, the MHC antigens fl~-microglobulin complex serving as the anchor- 
age site for the H-Y antigen. By using rat anti-H-Y antisera, we have studied 
the  association of the  H-Y  antigen with the  complex formed by the  major 
histocompatibility antigens and fl~-microglobulin on human lymphoid cells and 
mouse teratocarcinoma cells. 
The results reported here demonstrate that the  H-Y  antigen is associated 
with/32-microglobulin on the cell membrane. 
Materials and Methods 
Immune Sera 
ANTI-mY ANTISERA.  Anti-H-Y antisera were prepared in 8- to 12-wk-old female inbred Lewis 
rats by intraperitoneal injection of 2  ×  l0  s or 4  ×  107 spleen cells from male inbred Lewis rats. 
After six to eight weekly injections, rats were bled and the sera were stored at -28°C. Before use, 
the antisera were heat inactivated and absorbed with an equal volume of packed human female 
AB erythrocytes for 1 h at 4°C. Normal female Lewis rat serum was used as control. 
ANTI-~2-MICROGLOBULIN.  Rabbit antimurine  132-microglobulin serum  (no.  7036)  was  kindly 
* Supported by grants from the National Institutes of Health (CA 16355.01),  the Andrd Meyer 
Foundation, the Centre National de la Recherche Scientifique (269), the Ddlbgation Gdndrale ~ la 
Recherche Scientifique et Technique (73.7.1208 and 75.7.0745, the Institut National de la Sant6 et 
de la Recherche M6dicale). 
1  Abbreviations  used  in this paper:  EC, embryonal carcinoma; MHC, major histocompatibility 
complex; PBS, phosphate-buffered saline. 
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supplied by Dr. N. Tanigaki (11, 12). Two different rabbit anti-human ~2-microgiobulin sera were 
obtained from Doctors A. Colle and N. Tanigaki, respectively (13). 
ANTI-HLA SERA.  A  rabbit  anti-HLA serum  was kindly  provided by  Dr.  Y.  Tanigaki.  This 
xenogeneic  antiserum  was  absorbed  twice  with  an  equal  volume  of Daudi  cells,  a  human 
lymphoblastoid cell line lacking HLA antigen (14-16).  Human anti-HLA sera were obtained from 
multiparous  women.  Only  eluates  (17)  of anti-HLA  sera  from  platelets  were  used.  We  had 
previously ascertained that neither the rabbit anti-~2-microglobulin nor the anti-HLA used was 
contaminated by anti-H-Y activity (the anti-/~2-microglobulin  or anti-HLA sera absorbed on 
female cell  lines  no longer react  with Raji  cells). 
Cell Lines 
HUMAN CELL LINES.  The human lymphoblastoid cell lines were grown in RPMI 1640 medium 
supplemented with 10% fetal calf serum. They were obtained from Doctors J. Littlefield, G. Klein, 
W. Bodmer, P. Goodfellow, and P.Wernet and from am" own laboratory. 
The cell lines were derived either from Burkitt lymphomas: Daudi  (14),  Raji (18),  Chevalier 
(unpublished  data),  Ramos  (19),  BJAB  (20),  Namalwa  (21),  or from leukemic patients:  SKL-1 
(22), RPMI 8866. The other lymphoid cell lines were derived from normal peripheral lymphocytes 
(23, 24). 
SOMATIC HYBRID  CBLLS.  The origin and karyotypic characterization of the human 8 A Raji × 
Daudi hybrid have been described previously (25).  The human hybrid Daudi  ×  D 98/AH-2 was 
obtained by the Sendai virus fusion technique (26). D 98/AH-2, a line derived from HeLa female 
cells, is deficient in hypoxanthine phosphoribosyl transferase (27). The hybrid Daudi x  D 98/AH- 
2 clone was selected in hypoxanthine,  aminopterin, thymidine selective medium (28). 
The  human  Y  chromosomes  have  been  identified on  all  human  cell lines  by the  "atebrin 
fluorescence technique" (29) and a C banding technique (30). A minimum of 10 metaphases were 
analyzed for each cell line. 
Mouse Teratocarcinoma.  A number of different embryonal carcinoma cell lines (EC) and their 
differentiated derivatives were used. The culture and differentiation of embryonal carcinoma cells 
have been described previously (31). After 10-14 or 20 days in culture, differentiated cells were 
replated 48 h before testing. The cells were detached by treatment with EDTA solution (2 mM in 
phosphate-buffered saline [PBS]) and replated at 1/3 the initial density. 
Two of the cell lines were derived from testicular teratecarcinoma OTT 6050 of mouse strain 
129/Sv: the nullipetential F9 line (32) and the multipotential  PCC3/A/1 line (31). In neither of 
these lines could a Y chromosome be detected by cytogenetic techniques (31, 33, 34). 
The multipotential  EC  line PCC7-S  and  its  azaguanine-resistant  clone PCC7-S-AzaR1  were 
isolated  from  a  spontaneous  testicular  teratocarcinoma  arising  in  a  recombinant  (129  ×  B6) 
inbred  line (F7).  PCC7-S  is a  typical EC line in respect of morphological (i.e.  low cytoplasm/ 
nucleus ratio)  and immunological characteristics  (presence  of  F9 antigen according to  the  method 
previously described) (32).  It gives tumors that contain well-differentiated  tissues  belonging to 
the three embryonal germ layers.  Differentiation  in vitro  gives preferentially  nervous derivative 
types (S. Pfeiffer,  unpublished results). 
The cytogenetic analysis of  PCC7-S as well as of  its azaguanine-resistant clone is apparently 
euploid: 40 chromosomes  with X  and  Y  chromosomes  easily identifiable (Fig. 1). The  Y 
chromosome can  be  shown to  be  present in  tissues  of  the  tumors even  after  continuous  exponential 
growth for  more than 2 too.  No preferential  Y chromosome loss  was observed under our in vitro 
culture  conditions. 
Sperm cells  were prepared following  the  technique described previously (13,  35). 
Serological Techniques.  A  microlymphecytotoxicity test was used according to Mittal  (36). 
Selected rabbit complement was diluted  1:2 with fresh human  AB serum before use.  Raji cells 
were used as target cells in the standard assay when quantitative absorptions were performed as 
follows: 20  /~1 of undiluted antiserum  was mixed with variable amounts of cells for 1 h  at 4°C. 
After centrifugation, the supernate was tested for cytotoxic activity. 
The indirect immunofluorescence technique was used on human  and mouse cells in culture. 
Goat  anti-rat  IgG  (Hyland  Diagnostic  Div.,  Travenol  Laboratories,  Inc.,  Costa  Mesa,  Calif.) 
labeled  with  fluorescein  or  rhodamine  were  adsorbed  (vol/vol)  at  4°C  by  human  or  mouse 
fibroblasts. 
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FIG. i.  Banding pattern of  a PCC7-S cell.  Heat denaturation followed  by trypsin  treat- 
ment. The abnormality of  one of  the chromosomes 14 is not regularly observed. The Y 
chromosome is  present  in  all  metaphases. 
and  antiglobulin  sera  was  performed  as  follows:  I00 ~I  of  anti-H-Y  at  various  dilutions  was  added 
to  a pellet  of  5 x 10  s  cells.  After  incubation  for  I  h at  4°C  with  occasional  shaking, the  suspension 
was diluted  with PBS  and 4%  bovine serum  albumin  and washed  twice. The  pellet  was 
resuspended  in  100  ~l  of  antiglobulin  at  a  dilution  of  1:30,  incubated for  40  rain  at  4°C,  and  washed 
three  times.  The  final  pellet  was  spread  on  a  microscope slide,  air  dried,  and  fixed  in  the  cold  with 
methanol. The smear was then mounted in 80% glycerol  in  PBS and observed with  both an epi- 
illumination  fluorescence  and  a phase  contrast  microscope. 
For  HLA and fi~-microglobulin  labeling  we  followed  the  same procedure;  goat  anti-human IgG 
and goat anti-rabbit  IgG labeled with fluorescein  (Hyland Laboratories)  or rhodamine were 
absorbed on human or mouse fibroblasts  and stored  at -40°C before  used.  The relationship 
between H-Y, fi2-microglobulin  and HLA antigen has  been  studied  by  the  differential  redistribu- 
tion  immunofluorescence  method (37). 
Results 
Presence of the H-Y Antigen on Raft Cells.  l~i  is a male lymphoid cell line 
established  from  a  B~rkitt  lymphoma  (18).  The  results  of cytotoxicity  tests 
performed  on  Raji  cells  using  a  rat  anti-H-Y  serum  (properly  absorbed,  see 
Materials and Methods) are given in Fig. 2.90-100% of Raji cells were killed by 
anti-H-Y  serum  at  1/1  to  1/8  dilution.  This  cytotoxic  activity  was  completely 
abolished after absorption by 10 different male lymphoid lines or by absorption 
with peripheral lymphocytes from 5 different male donors. The cytotoxic activity 
was not changed after absorption with female lymphoid cell lines or peripheral 
lymphocytes from female donors. 
Because the H-Y antigen has previously been found on sperm (5-8) of several 
mammalian species including man but not on chicken spermatozoa,  absorption 
of the  anti-H-Y  activity  by  sperm  cells  was  studied  (Fig.  3).  The  cytotoxic FELLOUS  ET  AL.  61 
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FIG.  2.  Cytotoxic activity of anti-H-Y sere on Raji cells.  Curve (O),  unabsorbed serum; 
curve  ([:]),  serum absorbed with three different human male lymphoid lines; curve  (©), 
serum  absorbed with three different human female lymphoid lines.  For absorption,  see 
Materials and Methods. 
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FIG.  3.  Cytotoxic activity of anti-H-Y serum on Raji cells. Curve (Q), unabsorbed serum. 
The  anti-H-Y  serum  is  absorbed  with  human  sperm  (A);  mouse  spermatozoa  (O);  pig 
spermatozoa ([::]); chicken spermatozoa (A). For absorption, see Materials and Methods. 
activity of the rat anti-H-Y sera on Raji cells was removed after absorption with 
mouse, pig, and human spermatozoa. On the contrary, ~hicken spermatozoa did 
not  remove  this  anti-H-Y  activity.  Moreover,  in  a  quantitative  absorption 
experiment, 2.10 T  human or pig spermatozoa completely removed the anti-H-Y 
activity of 20/~l of undiluted serum, whereas l0  s chicken spermatozoa had no 
effect. 
The cytotoxic activity of nonimmune female Lewis rat sera was studied on 
Raji cells; two out of  six sera were found to be cytotoxic on Raji cells at a dilution 
of 1:2. However, this activity was equally well absorbed by male and female 
lymphoid  cell  lines.  Several  different  anti-H-Y  sera  were  analyzed.  Sera 62  H-Y  AND  ~2-MICROGLOBULIN  ASSOCIATION 
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Fro.  4.  Presence of H-Y  antigen on ]~ji  cells using indirect immunofluorescence test. 
Curve (@), unabsorbed serum; curve ([:]),  serum absorbed with male (Chevalier) lymphoid 
line;  curve (O),  serum absorbed with female (Namalwa) lymphoid line.  50 ~l of  pure anti- 
H-Y is absorbed with 2.5 x 10  ~  cells. 
obtained after  weekly injection  of 2.10  e spleen cells  had generally a higher 
activity  than those obtained by injecting  4.107  cells. 
The presence of H-Y antigen on Raji cells  could also  be demonstrated by 
indirect  immunofluorescence. The anti-H-Y activity  was revealed with a fluo- 
rescein-conjugated goat anti-rat  IgG. 80-90% of  cells  were labeled (Fig.  4). The 
labeling was removed after absorption with male lymphoid cells  but not with 
female cells. When  these experiments  were performed  at 37°C, caps were 
observed on 60% of  the labeled cells. 
Presence of H-Y Antigen on Different  Human Lymphoid Cell Lines.  The 
expression of H-Y antigen was examined on 12 lymphoid lines established from 
male donors and 10 lymphoid lines from female donors by direct lymphocytotoxic 
or absorption technique (Table I). None of the 10 female cell lines absorbed the 
anti-H-Y activity. On the contrary, 10 out of 12 male cell lines expressed H-Y 
antigen by absorption criteria. Of the H-Y positive cell lines, one, Chevalier, 
lacks HLA antigens but is ~2-microglobulin positive (Fellous et al. Manuscript 
in preparation). The two exceptional male lines that lacked H-Y antigen were 
Ramos  (19), which also lacks the Y chromosome, and Daudi,  which already 
lacks HLA and ~2-microglobulin.  By direct lymphocytotoxic and indirect im- 
munofluorescence assay,  the  H-Y  antigen was  detected on  Raji,  Chevalier, 
SKL-1 but not on the other seven male lymphoid lines. It should be noted that 
the presence of H-Y antigen could be detected only by absorption on most male 
lymphoid lines, as it has been already found on normal lymphocyte from other 
species (6). In this context Raji and Chevalier obtained from Burkitt lymphoma 
seem to be rather exceptional. 
Relationship Between the Expression of B2-M  icroglobulin and of  H-Y Antigen 
H/Y  ANTIGEN  IS  ABSENT  ON  DAUDI  CELL  BUT  IS  EXPRESSED  AFTER  CELL 
FUSION.  The Daudi  cell line carries the  Y  chromosome but  lacks the  H-Y 
antigen. It is already known that Daudi lacks the human/32-microglobulin and 
HLA antigens (15, 16, 38). It was therefore of particular interest to determine FELLOUS  ET  AL.  63 
TABLE  I 
Expression of H-Y Antigen on Human Lymphoblastoid Lines from Male and Female 
Donors 
Sex chromo-  Direct cyto-  Immunofluo-  Absorption* 
Cell lines  toxic test  rescence test  Presence  of 
somes  Killed cells  Labeled cells  H-Y antigen 
%  % 
From male donors 
Raji*  XY  100  98  Present 
Chevalier*  XY  100  70  Present 
SKLll  XY  60  60  Present 
JOST§  XY  0  0  Present 
ScTa§  XY  0  0  Present 
REMBI§  XY  0  0  Present 
H2LcL§  XY  0  0  Present 
RPMI 886611  XY  0  0  Present 
PGwl§  XY  0  0  Present 
ESwI§  XY  0  0  Present 
Daudi$  XY  0  0  Not present 
Ramos*  XX  0  0  Not present 
From female donors 
BJAB, Namalwa$  XX  0  0  Not present 
T51, Brel, SCBMB georget§  XX  0  0  Not present 
WT50, Maja, AUR Letule§  XX  0  0  Not present 
* Anti-H-Y activity test on Raji cell after absorption on lymphoid line. 
* Line from Burkitt lymphoma. 
§ Line from normal peripheral blood. 
II Line from leukemic patient. 
whether or not the absence of HLA, H-Y,  and B2-microglobulin on Daudi were 
related (Table II). 
Two types of somatic cell  hybrids  involving Daudi have been  analyzed:  (a) 
one  hybrid  (Raji  ×  Daudi)  clone  which  expresses  fl2-microglobulin  and  HLA 
(17,  39):  this hybrid also expresses the H-Y antigen  (Table II);  (b) one hybrid 
(Daudi  ×  D98 AH-2)  clone,  D98 AH-2,  being  a  human female  cell  line.  This 
hybrid,  which  has  a  Y  chromosome  derived  from  Daudi,  expresses  both  fl2- 
microglobulin and H-Y antigen. 
EXPRESSION OF H-Y ANTIGEN ON MOUSE TERATOCARCINOMA  CELL LINES.  The 
mouse embryonal carcinoma lines,  PCC7-S and PCC7-S-Aza~ which carry the 
Y  chromosome were  studied  (Table  HI).  They both lack  B2-microglobulin and 
the  H-Y  antigen.  After  3-4  wk  of culture  under conditions  allowing  in  vitro 
~differentiation,"  fl2-microglobulin becomes detectable by indirect immunofluo- 
rescence on about 1/3 of the cell population (Table III). Absorption experiments 
also showed the presence of H-Y antigen on these cells. An eventual correlation 
between  the appearance  of H-Y  antigen  and of/32-microglobulin  was  investi- 
gated  by double labeling  immunofluorescence  experiment  (see  Materials  and 
Methods).  All the cells which expressed H-Y antigen were also found to be/32- 
microglobulin  positive;  the  reverse  was  not  true.  Similarly,  the  mouse  em- 
bryonal carcinoma  cell  lines F9,  PCC4,  and LT1  (Table  III), which are XO or 64  H-Y  AND  ~2-MICROGLOBULIN  ASSOCIATION 
TABLE  II 
Relationship  between the Expression of Human  fl2- 
Microglobulin HLA and H-Y Antigen on Human Cell Lines 
Sex  chromo-  Cell  line 
somes 
Presence  of 
HLA  B2m*  H-Y 
Raji$  XY  +  +  + 
Daudi$  XY  -  -  - 
Raji  x  Daudi§  XY, XY  +  +  + 
D 98  XX  +  +  - 
Daudi  x  D 98§  XX, XY  +  +  + 
Chevaliers  XY  -  +  + 
* ~s-microglobulin. 
$ Line from Burkitt lymphoma. 
§ Hybrid cell. 
TABLE  III 
Presence of H-Y Antigen on Cell Mouse Teratocarinoma Lines 
Detectable antigen using 
Embryonal carcinoma line 
Presence  of 
Sex chro- 
differentiated 
type cells  mosomes  Absorption 
test* H-Y 
Immunofluorescence test 
Mouse B~- 
microglob-  H-Y,* la- 
ulin, la-  beled cells 
beled cells 
%  % 
F9  No  XO  -  0  0 
PCC4  No  XO  -  NTS  0 
LT1  No  XX  -  NT  0 
PCC7-S, 0 day  No  XY  -  0  0 
PCC7-S, 28 days§  Yes  XY  +  35  24 
PCC7-S Azaal, 0 day  No  XY  -  0  0 
PCC7-S Azaal, 24 days§  Yes  XY  +  NT  18 
PCC3/A/1, 0 day  No  XO  -  0  0 
PCC3/A/1, 30 days  Yes  XO  -  36  0 
* Anti-H-Y activity test on Raji cell after absorption on teratocarcinoma line. 
$ Not tested, 
§ Differentiation appears under conditions of differentiation in vitro. 
XX, lacked both H-Y antigen and/32-microglobulin.  PCC3/A]I  cells which are 
XO can differentiate in vitro and then express fl2-microglobulin but still do not 
express H-Y antigen. 
RELATION  BETWEEN  H-Y  AND  HUMAN  ~2-MICROGLOBULIN  ON  RAJI 
CELL.  Redistribution  experiments  were  performed  on  Raji  cells  to  analyze 
whether H-Y and ~-microglobulin were associated on the cell membrane (Table 
IV).  After  the  first  labeling  with  rabbit  anti-B2-microglobulin  (revealed  by 
fluorescein  or rhodamine  conjugated  anti-rabbit  Ig)  and  incubation  at  37°C, 
capping was observed on 70-80% of the labeled cells. If the second staining was 
performed at  0°C  with anti-H-Y  sera  (revealed  by rhodamine  or fluorescein- 
conjugated  anti-mouse  Ig),  90%  of the  cells  doubly  stained  (Fig.  5)  showed FELLOUS ET  AL.  65 
TABLE  IV 
Effect of Redistribution of Human fl~-Microglobulin  on the Distribution of H-Y Antigen 
on Raft Cell 
Second label-  Cells  labeled  Cells  labeled 
First  labeling  ing  for  H-Y  for  fl2m* 
Percent of  cells  where labeling 
of  human ~m  is  aggregated 
and 
H-Y aggre-  H-Y has a dif- 
gated at the  fuse labeling 
same place 
37°C  O°C 
Rabbit anti-  Anti  H-Y  fol- 
Bsm 1/200  lowed by 
and FITC  TRITC goat 
goat anti-  anti-mouse 
rabbit Ig  Ig 
Rabbit anti-  Anti-H-Y  fol- 
B~m 1/200  lowed by 
and TRITC  FITC goat 
goat anti-  anti-mouse 
rabbit Ig  Ig 
Anti H-Y and  Rabbit anti- 
FITC goat  ~m and 
anti-mouse  TRITC goat 
Ig  anti-rabbit 
Ig 
%  % 
90  99 
85  100 
87  99 
Cells  labeled  for  B2m 
92  8 
96  4 
Percent of cells where labeling 
for H-Y is aggregated and 
~2m aggre- 
gated at  the  ~2m has a dif- 
fuse  labeling, 
same place  100 
0 
Percent of cells where labeling 
of ~2m FITC is aggregated and 
Rabbit anti-  Rabbit anti- 
flsm 1/200  Bsm 1/50 
and FITC  and TRITC 
goat anti-  goat anti- 
rabbit Ig  rabbit Ig 
fl2m TRITC ag-  B2m TRITC 
%  gregated at the  has a diffuse 
same place  labeling 
100  95  5 
*Abbreviations  used  in  this  table:  /32m, fl2microglobulin; FITC,  fluorescein  isothiocyanate; 
TRITC, tetramethyl rhodamine isothiocyanate. 
cocapping of fl2-microglobulin and H-Y antigen.  However, in 4-8% of the cells 
the redistribution of fl2,microglobulin was not associated with a  correspondent 
capping of H-Y antigen. These latter results can tentatively be explained by the 
fact that in 5% of the cells where fl2-microglobulin caps (last line of Table IV), 
there is still fl~-microglobulin incompletely redistributed and left outside of the 
caps. No such cocapping between H-Y and B2-microglobulin was observed when 
H-Y antigen is the first to be aggregated. 
Discussion 
As compared with spermatozoa or epidermal cells, the Raji cell line turns out 
to be a useful target cell for studies of the H-Y antigen (5, 40): it is easy to grow 
and killable to 100% by rat anti-H-Y sera at a  dilution up to 1:8. 66  H-Y  AND  ~2-MICROGLOBULIN  ASSOCIATION 
FIG.  5.  Redistribution experiment of fi2-microglobulin  and H-Y on Raji  cells.  /]2-Micro- 
globulin were first  capped (right  panel) with rabbit anti-A3s-microglobulin  and fluorescein 
isothiocyanate-conjugated goat anti-rabbit  IgG. On the left  panel  are  shown the  correspond- 
ing cells  stained at 4°C with anti-H-Y sera and tetramethyl  rhodamine  isothiocyanate- 
conjugated  goat anti-mouse IgG. No rhodamine  labeling (anti-H-Y) is found outside the 
green cap (B2-microglobulin). 
Serological screening of male and female human lymphoid cell lines strongly 
suggests that the serologically detectable H-Y antigen is associated with the 
presence of the  Y  chromosome. The  H-Y  antigen is  expressed on  all  male 
lymphoid cell lines with only two exceptions: (a) the Ramos cell line which was 
established from a male donor and has lost the Y chromosome in culture, and 
(b)  the Daudi cell line which has a  Y chromosome. Recently, Ohno (10) has 
suggested that H-Y antigen used the major histocompatibility j32-microglobulin 
antigens complex as an anchorage site on the cell membrane. The experiments 
reported here were designed to test this hypothesis. The first striking result is 
the absence of H-Y antigen on Daudi cell, known to lack both ~2-microglobulin 
and HLA antigens. Cell hybrids between Daudi and D98 (a female cell line that 
expresses B~-microglobulin and HLA antigens) express the H-Y antigen. More- FELLOUS  ET  AL.  67 
over, Chevalier, a cell line that lacks HLA antigens but expresses/32-microglob- 
ulin, also expresses H-Y antigen. 
To  test  a  possible  association  between  HLA,  fl2-microglobulin,  and  H-Y 
antigen,  redistribution  experiments  between  H-Y  and  B2-micreglobulin  or 
between H-Y  and  HLA  were performed on  Raji  cells.  In the  redistribution 
experiments between /32-microglobulin  and H-Y antigen,  90%  cocapping was 
observed when fl2-microglobulin  was redistributed first, but not when the H-Y 
antigen is capped first. These results show that H-Y antigen is associated with 
fl2-microglobulin  on the cell membrane of Raji. No cocapping has been observed 
however when redistribution experiments with HLA and H-Y antigens were 
carried out. These results show clearly that in the cell membrane H-Y antigen 
is associated only with /32-microglobulin  but not with HLA antigen  (as sug- 
gested by Ohno). 
The association between H-Y  antigen and  B~-microglobulin  has also been 
found on mouse teratocarcinoma cells. The male pluripotent embryonal carci- 
noma lines PCC7-S and PCC7-AzaR1 carrying the Y chromosome lack beth H- 
Y and fl2-microglobulin.  During in vitro differentiation correlated appearance 
of both antigens was observed. Moreover, the cells that are H-Y positive are 
always /32-microglobulin positive.  On the contrary, /32-microglobulin positive, 
H-Y  negative cells were found,  a  result that  suggests that  during in  vitro 
differentiation B2-microglobulin might appear before H-Y antigen. 
The  presence of H-Y  antigen has  also  been described on  mouse morulae 
embryos (41). However, at this stage of embryonic development, we were unable 
to detect B~-microglobulin  (12). Although the presence of fl2-microglobulin  is 
apparently required for H-Y expression on adult cells, embryonic cells appear to 
express H-Y without expressing adult fl~-microglobulin.  On the embryo, H-Y 
antigen might be associated with an eventual embryonic form of fl2-microglob- 
ulin which has already been postulated (42). 
The association between H-Y and/32-microglobulin must be compared to the 
already described association between fl2-microglobulin  and other membrane 
antigens related by sequence similarities and coded by closely linked genes: 
major histocompatibility antigens (37), Tla antigen (43), or Qa antigen (44). 
fl2-Microglobulin  might behave as a  regulatory element in controlling the 
expression  of a  series  of cell  membrane antigens  during  development and 
differentiation. 
Summary 
The  expression  of the  H-Y  antigen  has  been  tested  on  several  human 
lymphoid lines and mouse teratocarcinoma cell lines during differentiation. The 
human male lymphoid cell line Raji is a very useful target for studies of the H- 
Y  antigen  by  lymphocytotoxicity test  with  rat  anti-H-Y  sera.  With  a  few 
exceptions, all cells carrying the Y chromosome were H-Y positive. One of the 
exceptions is the human Daudi cell line which, besides lacking H-Y antigen, 
also lacks fl2-microglobulin.  We have studied a possible association between the 
H-Y antigen,  fl2-microglobulin,  and HLA antigen with redistribution experi- 
ments. The results strongly suggest that H-Y antigen is not associated with 
HLA antigens but with B2-microglobulin. 68  H-Y  AND  ~2-MICROGLOBULIN  ASSOCIATION 
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